These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20173337)

  • 1. Generation of tau aggregates and clearance by autophagy in an inducible cell model of tauopathy.
    Wang Y; Krüger U; Mandelkow E; Mandelkow EM
    Neurodegener Dis; 2010; 7(1-3):103-7. PubMed ID: 20173337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Prion-like' propagation of mouse and human tau aggregates in an inducible mouse model of tauopathy.
    Sydow A; Mandelkow EM
    Neurodegener Dis; 2010; 7(1-3):28-31. PubMed ID: 20160454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.
    Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR
    J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression.
    Hamano T; Gendron TF; Causevic E; Yen SH; Lin WL; Isidoro C; Deture M; Ko LW
    Eur J Neurosci; 2008 Mar; 27(5):1119-30. PubMed ID: 18294209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy.
    Mocanu MM; Nissen A; Eckermann K; Khlistunova I; Biernat J; Drexler D; Petrova O; Schönig K; Bujard H; Mandelkow E; Zhou L; Rune G; Mandelkow EM
    J Neurosci; 2008 Jan; 28(3):737-48. PubMed ID: 18199773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs.
    Khlistunova I; Biernat J; Wang Y; Pickhardt M; von Bergen M; Gazova Z; Mandelkow E; Mandelkow EM
    J Biol Chem; 2006 Jan; 281(2):1205-14. PubMed ID: 16246844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
    Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
    Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic processing of tau.
    Wang Y; Garg S; Mandelkow EM; Mandelkow E
    Biochem Soc Trans; 2010 Aug; 38(4):955-61. PubMed ID: 20658984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy and antagonism of macroautophagy and chaperone-mediated autophagy in a cell model of pathological tau aggregation.
    Wang Y; Martinez-Vicente M; Krüger U; Kaushik S; Wong E; Mandelkow EM; Cuervo AM; Mandelkow E
    Autophagy; 2010 Jan; 6(1):182-3. PubMed ID: 20023429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interneuronal transfer of human tau between Lamprey central neurons in situ.
    Kim W; Lee S; Jung C; Ahmed A; Lee G; Hall GF
    J Alzheimers Dis; 2010; 19(2):647-64. PubMed ID: 20110609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant.
    Sydow A; Van der Jeugd A; Zheng F; Ahmed T; Balschun D; Petrova O; Drexler D; Zhou L; Rune G; Mandelkow E; D'Hooge R; Alzheimer C; Mandelkow EM
    J Neurosci; 2011 Feb; 31(7):2511-25. PubMed ID: 21325519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors.
    Messing L; Decker JM; Joseph M; Mandelkow E; Mandelkow EM
    Neurobiol Aging; 2013 May; 34(5):1343-1354. PubMed ID: 23158765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tau aggregation in cell models of tauopathy.
    Khlistunova I; Pickhardt M; Biernat J; Wang Y; Mandelkow EM; Mandelkow E
    Curr Alzheimer Res; 2007 Dec; 4(5):544-6. PubMed ID: 18220518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3zeta protein.
    Sadik G; Tanaka T; Kato K; Yanagi K; Kudo T; Takeda M
    Biochem Biophys Res Commun; 2009 May; 383(1):37-41. PubMed ID: 19324008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation.
    Schindowski K; Belarbi K; Bretteville A; Ando K; Buée L
    Genes Brain Behav; 2008 Feb; 7 Suppl 1(1):92-100. PubMed ID: 18184373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing.
    Wang Y; Martinez-Vicente M; Krüger U; Kaushik S; Wong E; Mandelkow EM; Cuervo AM; Mandelkow E
    Hum Mol Genet; 2009 Nov; 18(21):4153-70. PubMed ID: 19654187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.
    Sydow A; Van der Jeugd A; Zheng F; Ahmed T; Balschun D; Petrova O; Drexler D; Zhou L; Rune G; Mandelkow E; D'Hooge R; Alzheimer C; Mandelkow EM
    J Mol Neurosci; 2011 Nov; 45(3):432-7. PubMed ID: 21822709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
    Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
    Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.
    Sorrentino G; Bonavita V
    Neurol Sci; 2007 Apr; 28(2):63-71. PubMed ID: 17464468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.